已阅
亚泰集团
亚泰集团网站群:
建材
地产
医药
亚泰投资
总经理信箱
会员登录
免费注册
本站
站群
EN
|
移动门户
联系我们
人力资源
患者社区
医生专栏
参一学术交流
产品展厅
新闻资讯
企业概况
联系方式
药物警戒
廉洁举报
职业发展平台理念
在线申请
招聘职位
表格下载
肿瘤健康常识
优惠政策
健康服务
微信公众平台
会议信息
视频专区
专业服务
微信公众平台
典型病例
学术活动
科研课题
Rg3文献分享
癌症研究进展
参一胶囊
人参皂苷RG3原料
茶碱缓释片
心脑康胶囊
复方氨酚烷胺片
肾复康胶囊
阿司匹林肠溶片
盐酸二甲双胍片
招商信息
集团新闻
产业新闻
企业新闻
营销快讯
企业简介
企业文化
企业资质
公司简介
企业文化
企业资质
新闻资讯
集团新闻
产业新闻
企业新闻
营销快讯
企业新闻
当前位置:
首页
>
企业新闻
2024-03-15
【会议预告】3月19日|抗血管治疗策略交流
2024-03-15
亚泰制药成功召开2024年第三期线上患者教育会议
2024-03-11
【会议预告】3月14日|乳腺癌辅助治疗研究分析与思考及病例分享
2024-03-01
亚泰制药成功召开2024年第二期线上患者教育会议
2024-02-26
【会议预告】2月27日|中医药在肿瘤治疗过程中的应用
2024-02-23
“参”临其境 “一”路相伴——肺癌病例3
2024-02-16
“参”临其境 “一”路相伴——肺癌病例2
2024-02-09
“参”临其境 “一”路相伴——肺癌病例1
2024-02-02
参一胶囊成功召开2024年第二期空中课堂线上学术会议
2024-01-26
【会议预告】2月1日|抗血管治疗策略交流
2024-01-26
参一胶囊成功召开2024年第一期空中课堂线上学术会议
2024-01-19
【会议预告】1月25日|抗血管治疗策略交流
2024-01-12
亚泰制药成功召开2024年第一期线上患者教育会议
2024-01-05
【会议预告】1月10日|胃癌肿瘤疾病患者健康教育宣教
2023-12-29
经动脉栓塞术联合人参皂苷Rg3治疗肝癌的研究
2023-12-22
三氧化二砷联合人参皂苷Rg3对移植瘤肝癌细胞凋亡的影响
2023-12-15
人参皂苷Rg3联合5-氟尿嘧啶对肝癌荷瘤小鼠的抑瘤作用
2023-12-08
人参皂苷Rg3对小鼠肝癌血管形成的影响
2023-12-01
人参皂苷Rg3联合经导管动脉化疗栓塞(TACE)治疗晚期肝癌患者的前瞻性...
2023-11-24
长春瑞滨合并顺铂NP加参一胶囊或安慰剂治疗晚期非小细胞肺癌的多中心...
ttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttt ttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttt ttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttt ttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttt ttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttt ttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttt ttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttt ttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttt ttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttt ttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttt ttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttt ttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttt ttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttt ttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttt ttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttt ttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttt ttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttt ttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttt
联系方式:0431-84970027
吉ICP备09008397号-5
互联网药品信息服务资格证书(吉)-非营业性-2019-0097
Copyright © 2015 YATAI GROUP All Rights reservedved.参一胶囊
吉林亚泰(集团)股份有限公司 版权所有
技术支持:亚泰智能科技有限公司、北京拓尔思信息技术股份有限公司
法律声明
加入我们
网站地图
在线交流